Is 4-methylephedrone, an Ecstasy of the twenty first century?
A capsule, presumed to contain ecstasy, was seized in 2007 and transmitted to the laboratory of the IRCGN for confirmation purpose. However, after chemical analysis using ion mobility spectrometry, gas chromatography-electron ionisation mass spectrometry (GC-EI/MS), nuclear magnetic resonance spectr...
Gespeichert in:
Veröffentlicht in: | Annales de toxicologie analytique 2009-01, Vol.21 (4), p.169-177 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A capsule, presumed to contain ecstasy, was seized in 2007 and transmitted to the laboratory of the IRCGN for confirmation purpose. However, after chemical analysis using ion mobility spectrometry, gas chromatography-electron ionisation mass spectrometry (GC-EI/MS), nuclear magnetic resonance spectroscopy (NMR), and liquid chromatography, electrospray ionisation mass spectrometry (LC-ESI/MS), the substance was identified as 4-methylephedrone and not as ecstasy. This case was an example of the development of new addictive drugs, specifically designed to by-pass current legislation, and generally called `designer drugs'.Original Abstract: L'analyse d'une substance contenue dans une gelule, transmise pour analyse au laboratoire de l'IRCGN en mai 2007, et pe a priori etre de l'ecstasy, a ete identifiee differemment comme etant de la 4-methylephedrone apres avoir ete analysee par spectrometrie de mobilite ionique, chromatographie en phase gazeuse couplee a la spectrometrie de masse sous ionisation electronique (GC-EI/MS), resonance magnetique nucleaire (RMN), et couplage de la chromatographie en phase liquide a la spectrometrie de masse en mode electrospray (LC-ESI/MS). Ce cas constitue un exemple de l'apparition sur le marche des stupefiants illicites de nouvelles substances specifiquement concues par des chimistes pour contourner les regulations et controles prevalant en France, souvent nommees designer drugs. |
---|---|
ISSN: | 0768-598X 1961-9480 |
DOI: | 10.1051/ata/2009048 |